Bluejay Diagnostics, Inc.
BJDX
$1.95
$0.063.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.68% | 2.46% | -1.50% | -15.06% | -19.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.53% | -13.58% | -25.75% | -34.09% | -30.47% |
| Operating Income | 3.53% | 13.58% | 25.75% | 34.09% | 30.47% |
| Income Before Tax | 11.27% | 20.24% | 28.39% | 25.54% | 22.46% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.27% | 20.24% | 28.39% | 25.54% | 22.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.27% | 20.24% | 28.39% | 25.54% | 22.46% |
| EBIT | 3.53% | 13.58% | 25.75% | 34.09% | 30.47% |
| EBITDA | 3.55% | 13.56% | 23.93% | 31.07% | 26.58% |
| EPS Basic | 92.24% | 88.94% | -- | -- | -- |
| Normalized Basic EPS | 41.08% | -9.73% | -- | -- | -- |
| EPS Diluted | 92.24% | 88.94% | -- | -- | -- |
| Normalized Diluted EPS | 41.08% | -9.73% | -- | -- | -- |
| Average Basic Shares Outstanding | 900.67% | 2,014.23% | -- | -- | -- |
| Average Diluted Shares Outstanding | 900.67% | 2,014.23% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |